A new approach to the treatment of sleep disorders in patients with cerebrovascular diseases
Rudenko, A.E.; Korzhenevskiĭ, L.V.; Bashkirova, L.M.
Likars'ka Sprava 2: 55-59
2003
ISSN/ISBN: 1019-5297 PMID: 12774477 Document Number: 556940
A positive result has been obtained in treating sleep disorders in patients with chronic vascular affections of the brain with using the drugs donormyl and sonnate-KM [symbol: see text]. Donormyl is recommended for use in sleep disturbances (not very prolonged and not profound insomnia) in a 10-day therapeutic course as a first-choice drug.